Download FREE Report Sample
Download Free sampleLateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
LFA-based Cardiac Market contains market size and forecasts of LFA-based Cardiac in Global, including the following market information:
Global LFA-based Cardiac Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global LFA-based Cardiac market was valued at 3699.5 million in 2021 and is projected to reach US$ 6161.8 million by 2028, at a CAGR of 7.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Troponin I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of LFA-based Cardiac include Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioM?rieux, Thermo Fisher, Ortho Clinical Diagnostics and LSI Medience Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the LFA-based Cardiac companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global LFA-based Cardiac Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global LFA-based Cardiac Market Segment Percentages, by Type, 2021 (%)
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Global LFA-based Cardiac Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global LFA-based Cardiac Market Segment Percentages, by Application, 2021 (%)
Laboratory Testing
Point-of-care Testing
Global LFA-based Cardiac Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global LFA-based Cardiac Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies LFA-based Cardiac revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies LFA-based Cardiac revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioM?rieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
